参与物
| 角色 | 名称 | HCID | 投料 |
|---|
| 反应物 | 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 | HCID 15908 | — |
| 反应物 | 1-羟基苯并三唑(HOBT) | HCID 75771 | — |
| 反应物 | 2,1,3-苯并噻二唑-5-甲酸 | HCID 602011 | — |
| 反应物 | N-甲基四氢-2H-吡喃-4-胺 | HCID 6991950 | — |
| 催化剂 | 4-二甲氨基吡啶(DMAP) | HCID 14284 | — |
| 溶剂 | N,N-二甲基甲酰胺 | HCID 6228 | — |
| 溶剂 | 三乙胺 | HCID 8471 | — |
| 产物 | N-Methyl-N-(tetrahydro-2H-pyran-4-yl)-[2,1,3]-benzothiadiazole-5-carboxamide | HCID 25104408 | — |
反应步骤
N-Methyltetrahydro-2H-pyran-4-amine (0.4 g, 3.4 mmol), [2,1,3]-benzothiadiazole-5-carboxylic acid (0.23 g, 1.4 mmol), DMAP (0.2 g: 1.6 mmol), HOBT (0.2 g, 1.5 mmol), triethylamine (1.0 ml) and EDCI (1 g, 6.4 mmol) were dissolved in DMF (30 ml). The mixture was stirred at room temperature for 18 h and then concentrated under vacuum. Chloroform (100 ml) was added and the mixture washed with water (100 ml) and H2SO4 (→pH 2) and NaHCO3 solution (100 ml). The aqueous was extracted with chloroform (100 ml) and the combined organics were dried (MgSO4), concentrated under vacuum, and the crude product was purified on a silica gel column eluting with chloroform/THF (90:10), to give the product as an oil which crystallized on standing. Mp=106-108° C., 1H NMR (300 MHz, CDCl3, rotamers) δ 8.06 (d, J=9.0 Hz, 1H); 8.01 (s, 1H); 7.60 (d, J=9.0 Hz, 1H); 4.92-4.75 and 4.15-3.10 (m, 5H); 3.10-2.80 (m, 3H) and 2.05-1.50 ppm (s, 4H).
来源与证据
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 专利号 | US08013003B2 |
|---|
| 来源数据集 | uspto-grants-2011_09 |
|---|
| ORD ID | ord-3b7ee58a101d430280d12cda2d36b418 |
|---|
| 来源说明 | uspto-grants-2011_09 |
|---|